Description of the active substance:
This information is a reference and it is not enough that the drug has been prescribed by a doctor ..
PHARMACHOLOGIC EFFECT
Causes the growth of specific antibodies to Neisseria meningitidis serogroups A, C, W 135 and Y.
INDICATIONS
Prevention of meningococcal infection caused by meningococcus groups A and C in children and adults.
DOSING MODE
Single vaccination starting at 18 months of age in a single dose, regardless of age. The vaccine is given SC or I / m.
SIDE EFFECT
Very rarely: (more likely in adults) in the first 72 hours after administration - minor fever, chills, weakness; slight and short reddening of the skin and soreness at the site of administration of the vaccine.
CONTRAINDICATIONS
Acute and chronic diseases.
PREGNANCY AND LACTATION
Pregnancy and lactation are not contraindications in adverse epidemic situations.
APPLICATION FOR CHILDREN
Children under the age of 18 months are not eligible for vaccination, except for epidemic situations, since for component A of the vaccine, immunity can develop from 3 months already, but on component C - it practically does not develop.
SPECIAL INSTRUCTIONS
Children under the age of 18 months are not eligible for vaccination, except for epidemic situations, since for component A of the vaccine, immunity can develop from 3 months already, but on component C - it practically does not develop.
